Citeline Podcasts
1,366 episodes - English - Latest episode: 3 days ago - ★★★★★ - 24 ratingsCiteline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Launch of Citeline Pharma Intelligence Awards Japan 2023 (Bilingual Podcast)
February 10, 2023 00:27 - 5 minutes - 11.7 MBAnnouncing the 2nd Citeline Pharma Intelligence Awards Japan, which will take place in Tokyo on 17 October. Entries are now open with a deadline of 10 July. Check out the links below for all the information on categories, judges, how to enter, table bookings and sponsorship opportunities. See you in Tokyo! English-language event site is here: https://pharmaintelligence.informa.com/citelinepharmaintelligenceawards2023 Japanese-language event site is here: https://pharmaintelligence.informa.c...
The future of mifepristone in America, with professor Greer Donley
February 08, 2023 13:50 - 29 minutes - 14 MBThe future of mifepristone in America, with professor Greer Donley by Citeline
DMHC’s financial analysts discuss M&As, the vaccine market, and biosimilars
February 08, 2023 09:44 - 41 minutes - 19.2 MBDMHC’s financial analysts discuss M&As, the vaccine market, and biosimilars by Citeline
Financial PodcDMHC’s financial analysts discuss M&As, the vaccine market, and biosimilarsast
February 08, 2023 09:44 - 41 minutes - 19.2 MBFinancial PodcDMHC’s financial analysts discuss M&As, the vaccine market, and biosimilarsast by Pharma Intelligence
2023년 글로벌 제약바이오 업계에 무슨 일이?
February 07, 2023 23:48 - 4 minutes - 10.4 MB올해 글로벌 제약바이오 업계의 자금조달 환경을 전망한 Scrip 기사를 요약한 내용입니다. https://scrip.pharmaintelligence.informa.com/SC147593/Scrip-AsksWhat-Does-2023-Hold-For-Biopharma-Part-1-The-Funding-Environment
Inside medical research charity LifeArc, with CEO Melanie Lee
February 07, 2023 15:04 - 28 minutes - 12.7 MBInside medical research charity LifeArc, with CEO Melanie Lee by Citeline
Prebiotics And Consumer Health: Opportunity, Regulation and Future, With Clasado’s Per Rehné
February 06, 2023 10:33 - 33 minutes - 75.7 MBIn this episode, HBW Insight interviews Per Rehné, CEO of UK-based microbiome specialists Clasado Biosciences, about the exciting world of prebiotics. Essentially food for your gut microbiome, prebiotics have benefitted from a worldwide boom in preventative health in recent years, as well as a critical mass of clinical research showing the significant role that the gut plays in health, immunity and even stress and anxiety. In this fascinating discussion, Rehné explains the science behind preb...
Scrip’s Five Must-Know Things – 6 February 2023
February 06, 2023 03:00 - 16 minutes - 37.5 MBQuick Listen: Scrip's Five Must-Know Things https://scrip.pharmaintelligence.informa.com/SC147859/Quick-Listen-Scrips-Five-MustKnow-Things
Drug Fix: US FDA Loses Gene Therapy Expert, Humira Biosimilars Launch, FDA Allows In-Person Meetings
February 03, 2023 18:33 - 31 minutes - 19.6 MBPink Sheet reporters and editors consider the impact of FDA Office of Tissues and Advanced Therapies Director Wilson Bryan’s retirement, the launch of Humira biosimilars and its effect on the biologic market, as well as the FDA moving to hybrid meetings with sponsors.
Medtech Connect: MedTech Europe's Alexander Olbrechts On The European Health Data Space
February 03, 2023 09:36 - 16 minutes - 14.3 MBIn this episode of new podcast series Medtech Connect, Medtech Insight’s regulatory writer for Europe, Eliza Slawther, interviews Alexander Olbrechts, director for digital health at the European trade body Medtech Europe, to find out more about the proposed European Health Data Space initiative and what it means for the medical device industry.
Interview with Neil Warma, president and CEO of Genexine
February 01, 2023 23:39 - 28 minutes - 23.8 MBGenexine’s Neil Warma talks to Scrip’s Jung Won Shin about the company’s strategy, pipeline and plans and the wider environment for Korean biopharma firms looking to go global. From Science To Commercialization: How Genexine Is Making The Shift https://scrip.pharmaintelligence.informa.com/SC147834/From-Science-To-Commercialization-How-Genexine-Is-Making-The-Shift
Biotech Is Solving Beauty’s Sustainability Challenges, Elevating R&D, With Amyris’ Annie Tsong
February 01, 2023 17:08 - 20 minutes - 9.3 MBIn this episode, HBW Insight chats with Annie Tsong, chief strategy and product officer at Amyris, Inc., an Emeryville, Calif.-based company that uses synthetic biotechnology to produce clean beauty, personal care, wellness and food ingredients for thousands of brands across the globe. Leading the firm’s ingredient development pipeline, Tsong discusses the science as well as the benefits of biotech alternatives to traditional beauty ingredients – including sustainability and better performanc...
【3分で解説 世界のファーマ】第8回 2023年JPモルガン・ヘルスケアカンファレンス 3つの焦点とは
February 01, 2023 00:19 - 4 minutes - 9.45 MB世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 今回取り上げた記事はこちら 「J.P. Morgan Was Back, But Not With A Roar（邦題意訳：帰ってきたJPモルガンカンファレンス、ただし勢いはやや控えめ）」 https://scrip.pharmaintelligence.informa.com/SC147649/JP-Morgan-Was-Back-But-Not-With-A-Roar 「The Best Of J.P. Morgan – Valuations, Deals And The IRA（邦題意訳：JPモルガン総まとめ 企業評価から提携、IRAまで）」 https://scrip.pharmaintelligence.informa.com/SC147668/The-Best-Of-JP-Morgan--Valuations-Deals-And-The-IRA 世界の製薬業界ニ...
Scrip’s Five Must-Know Things – 30 January 2023
January 30, 2023 04:00 - 15 minutes - 34.6 MBQuick Listen: Scrip's Five Must-Know Things https://scrip.pharmaintelligence.informa.com/SC147782/Quick-Listen-Scrips-Five-MustKnow-Things
Eli Lilly’s Diogo Rau on the company’s digital future
January 27, 2023 11:18 - 22 minutes - 10.5 MBEli Lilly’s Diogo Rau on the company’s digital future by Citeline
Mavacamten in oHCM: Q&A with Cardiology Specialist, Lynn Cronin, MD
January 25, 2023 14:53 - 15 minutes - 3.48 MBDr. Cronin provides her perspectives on identification, treatment, and management of oHCM patients using the novel cardiac myosin inhibitor, mavacamten. Lynn Cronin, MD, FACC is board-certified in cardiology with clinical interests in adult congenital heart disease, valvular heart disease, and chronic ischemic heart disease. She is affiliated with multiple hospitals in the Holland, MI area including Spectrum Health.
Digital Health Roundup: CES 2023 Highlights; US FDA VR, AR Website; Bayer’s Powers Up On Radiology
January 25, 2023 07:07 - 10 minutes - 18.8 MBIn this month’s Digital Health Roundup, Medtech Insight’s Marion Webb provides highlights from the recent CES 2023 conference in Las Vegas. Reed Miller discusses Abbott’s VR partnership with the Blood Centers for America and Barnaby Pickering highlights Bayer’s jump into medtech with its buyout of Blackford Analysis. Listen to the podcast via the player below: Medtech Insight articles addressing topics discussed in this episode:
Digital Health Roundup: CES 2023 Highlights; US FDA VR, AR Website; Bayer’s Powers Up On Radiology
January 24, 2023 23:21 - 10 minutes - 18.8 MBIn this month’s Digital Health Roundup, Medtech Insight’s Marion Webb provides highlights from the recent CES 2023 conference in Las Vegas. Reed Miller discusses Abbott’s VR partnership with the Blood Centers for America and Barnaby Pickering highlights Bayer’s jump into medtech with its buyout of Blackford Analysis. Medtech Insight articles addressing topics discussed in this episode: CES 2023: Competition Spikes In Cuffless Blood Pressure Monitoring https://medtech.pharmaintelligence.info...
Panther Biopartners Discuss The SMO Strategy
January 24, 2023 17:46 - 28 minutes - 35.5 MBPanther Biopartners Discuss The SMO Strategy by Pharma Intelligence
Panthera Biopartners Discuss The SMO Strategy
January 24, 2023 17:46 - 28 minutes - 35.5 MBPanthera Biopartners Discuss The SMO Strategy by Citeline
Scrip’s Five Must-Know Things – 23 January 2023
January 23, 2023 02:44 - 15 minutes - 36.1 MBhttps://scrip.pharmaintelligence.informa.com/SC147711/Quick-Listen-Scrips-Five-MustKnow-Things
Cardio Conversations: Interview With PFA Pioneer Steven Mickelsen
January 21, 2023 00:26 - 38 minutes - 43.8 MBIn the first episode of Medtech Insight’s new podcast series focused on cardiovascular technology, editor Reed Miller talks to Steven Mickelsen, one of the founders of Farapulse and Field Medical, about pulsed field ablation, an emerging technology that is changing electrophysiology. Related articles: Acutus Names David Roman As New CEO; Mickelsen Departs Company https://medtech.pharmaintelligence.informa.com/MT145640/Acutus-Names-David-Roman-As-New-CEO-Mickelsen-Departs-Company Boston Sci...
Medtech Monthly: Eargo CEO Discusses OTC Hearing Aids.
January 20, 2023 21:02 - 25 minutes - 16.1 MBMedtech Monthly: Eargo CEO Discusses OTC Hearing Aids. by Citeline
Drug Fix: More US FDA Communication Problems, 2022 Approval Trends, Cancer Drug Dosing Guidance
January 20, 2023 17:36 - 36 minutes - 22.3 MBPink Sheet reporters and editors discuss concerns related to the FDA’s announcement of a COVID-19 vaccine safety investigation, 2022 novel drug approval data, and a new guidance on cancer vaccine dose optimization.
Post - ASH Podcast
January 20, 2023 15:13 - 24 minutes - 11.7 MBPost-ASH report https://service.datamonitorhealthcare.com/hkc/thought-leadership/article244408.ece AML disease analysis report https://service.datamonitorhealthcare.com/hkc/disease/oncology/leukemia/acute-myeloid-leukemia/disease-analysis/article214159.ece Multiple myeloma disease analysis report https://service.datamonitorhealthcare.com/hkc/disease/oncology/other-hematological-cancers/multiple-myeloma/disease-analysis/article219424.ece CLL disease analysis report https://service.datamonitor...
Scrip’s Five Must-Know Things – 16 January 2023
January 16, 2023 03:34 - 15 minutes - 36 MBhttps://scrip.pharmaintelligence.informa.com/SC147669/Quick-Listen-Scrips-Five-MustKnow-Things
Drug Fix: Leqembi Approved, Medicare Price Negotiation Timeline, AAM CEO Departure
January 13, 2023 15:49 - 30 minutes - 19.2 MBPink Sheet reporters and editors discuss the take-aways from Leqembi’s approval as an Alzheimer’s treatment, the new timeline for information collection and comment on Medicare price negotiations, and the reasons a generic drugs trade association CEO departed.
Medtech Connect Episode 1: How Do We Regulate Software As A Medical Device?
January 06, 2023 17:05 - 32 minutes - 24.5 MBIn this first episode of Medtech Connect, Medtech Insight’s regulatory reporter Hannah Daniel interviews Foley and Lardner partner Kyle Faget about the complexities behind regulating software as a medical device (SaMD). Many companies are unsure if their software is even regulated by the FDA, let alone how to go about the approval process. From managing cybersecurity risks to navigating digital health policy, Faget does it all, and she gives us insight into the regulatory landscape of SaMD in...
2022년 글로벌 제약업계 5대 뉴스는? (Korean-language podcast)
January 04, 2023 23:50 - 4 minutes - 9.18 MB2022년 주목받은 톱 5 제약업계 뉴스에 대한 Scrip 기사를 요약한 내용입니다.
CLP, Cosmetics And New Hazard Classes In The EU’s Haste To Be Green, With Louise Witter
December 19, 2022 19:48 - 1 hour - 32 MBIn this episode, HBW Insight chats with Louise Witter, director and principal consultant at UK-based Chemical Legislation Professionals, about proposed revisions to the EU’s Classification, Labeling and Packaging Regulation (CLP) to introduce new hazard classes, including for endocrine disruptors. The discussion, just prior to the European Commission’s adoption of the proposal on 19 December, ranges from implications for cosmetics companies to reflections on the EU Green Deal, which may be ou...
Medtech Insight’s Medtech 100 and 2023 Industry Outlook
December 16, 2022 18:38 - 9 minutes - 4.41 MBMedtech Insight’s Medtech 100 and 2023 Industry Outlook by Citeline
Drug Fix: Accelerated Approvals Drop, CMS’s Generic Tiers Reg, Cytokinetics’ Adcomm Loss
December 16, 2022 18:01 - 33 minutes - 21.3 MBPink Sheet reporters and editors discuss a projected decline in accelerated approvals by the US FDA, a new CMS proposed rule requiring generic drug cost sharing tiers, and the negative advisory committee recommendation for Cytokinetics’ proposed heart failure treatment.
Citeline Awards 2023 - Entry hints and tips podcast
December 15, 2022 14:02 - 16 minutes - 7.84 MBListen Citeline's Executive Director of Clinical Intelligence, Karen Currie and Executive Editor Commerical/R&D, Mary Jo Laffler discussing the hints and tips for entering the Citeline Awards 2023, as well as information on new categories. Find out more on our website: https://pharmaintelligence.informa.com/citelineawards2023 #CitelineAwards
レポート要約2／2021年の臨床試験の総括、ポストパンデミックの世界はニューノーマルを迎えたのか (Japanese-language podcast)
December 13, 2022 23:50 - 4 minutes - 10.8 MBレポート『2021年の臨床試験の総括、ポストパンデミックの世界はニューノーマルを迎えたのか（2022年11月発行）』を要約し、短い音声ファイルにまとめました。臨床試験データベース「Trialtrove」がカバーする全治療領域に関して、2021年に開始された第I～III相試験の概要と、ポストパンデミックの製薬業界に影響を及ぼす主な疾患、企業、地理的要因の分析に焦点を当てました。フルレポートをお読みになりたい方は、下記のURLからダウンロードしてください。 【日本語版】 https://images.intelligence.informa.com/Web/InformaUKLimited/%7Bed9ec7f6-a609-4057-a3ab-b3b657aa8224%7D_Clinical_Trials_Round-up_2021_PInews_JP_CMPRSD.pdf 【英語版】 https://images.intelligence.informa.com/Web/InformaUKLimited/%7B60095ba9-eb79-4c64-8612-0422e39971...
SK바이오팜 CTO: 오픈이노베이션의 다양성 (Korean-language podcast)
December 13, 2022 00:50 - 3 minutes - 8.99 MBSK바이오팜의 오픈이노베이션 전략과 신약개발 성공요인에 대한 Scrip의 맹철영 SK바이오팜 신약개발부문장(CTO) 인터뷰 기사 내용입니다. https://scrip.pharmaintelligence.informa.com/SC146933/SK-Biopharms-CTO-On-Diversity-In-Open-Innovation
Scrip’s Five Must-Know Things – 12 December 2022
December 12, 2022 03:05 - 16 minutes - 38.4 MBQuick Listen: Scrip's Five Must-Know Things https://scrip.pharmaintelligence.informa.com/SC147511/Quick-Listen-Scrips-Five-MustKnow-Things
Drug Fix: Innovation v. Access, AAM CEO Departs, Concerns About US FDA’s IND Regulations
December 09, 2022 19:06 - 38 minutes - 24.4 MBPink Sheet reporters and editor consider the line between therapeutic innovation and affordability, the Association for Accessible Medicines searching for a new CEO, and questions about IND regulations and drug repurposing.
Scrip’s Five Must-Know Things – 5 December 2022
December 05, 2022 02:52 - 15 minutes - 34.7 MBScrip’s Five Must-Know Things – 5 December 2022 by Citeline
Vision Possible: Why Eyestem Is ‘Bullish’ About Its Dry AMD Candidate
November 30, 2022 07:15 - 29 minutes - 11.1 MBEyestem’s founder and CEO, Dr Jogin Desai, talks to Scrip about progress made by the firm’s experimental treatment for dry age-related macular degeneration, cell and gene therapy pricing considerations and the wider competitive landscape. The company is also developing treatments for retinitis pigmentosa and idiopathic pulmonary fibrosis.
Digital Health Roundup: HLTH2022 Highlights, EU Updates, Diabetes Medtech Monthly
November 29, 2022 19:36 - 4 minutes - 2.35 MBIn this month’s Digital Health Roundup, Medtech Insight’s Marion Webb provides highlights from the recent HLTH conference in Las Vegas. Reed Miller and Barnaby Pickering offer an overview of the highly competitive diabetes tech market. We also talk about digital health in Germany and Europe. Medtech Insight articles addressing topics discussed in this episode: HLTH Conference Promises Festival Vibe On One Big Stage; Health Equity, Women’s Health, Digital Health https://medtech.pharmaintelli...
3分で解説 世界のファーマ】第7回 米国で見えてきたRWDの注意点
November 29, 2022 00:54 - 3 minutes - 7.77 MB世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 今回取り上げた記事はこちら The Real World Is Not Enough: Comparability Is Common Obstacle For RWE In US FDA Decisions 「（邦題意訳）リアルワールド、見えた弱点 米国FDAの承認で比較可能性がネックに」 https://pink.pharmaintelligence.informa.com/PS147051/The-Real-World-Is-Not-Enough-Comparability-Is-Common-Obstacle-For-RWE-In-US-FDA-Decisions 世界の薬事規制ニュースPink Sheet（ピンクシート）とは？ https://www.citeline.com/ja-jp/products-services/regulatory-and-compl...
Scrip’s Five Must-Know Things – 28 November 2022
November 28, 2022 00:59 - 14 minutes - 32.2 MBhttps://scrip.pharmaintelligence.informa.com/SC147431/Quick-Listen-Scrips-Five-MustKnow-Things
Scrip’s Five Must-Know Things – 21 November 2022
November 21, 2022 01:55 - 15 minutes - 35.5 MBQuick Listen: Scrip's Five Must-Know Things https://scrip.pharmaintelligence.informa.com/SC147398/Quick-Listen-Scrips-Five-MustKnow-Things
Harbour BioMed CEO Podcast20221118
November 18, 2022 06:43 - 56 minutes - 25 MBSuzhou and Boston-based Harbour BioMed recently shifted strategy, divesting its site in Suzhou to WuXi in a bid to be “more focused, efficient and nimble” to emerge stronger post-pandemic, says the company founder, chairman and CEO Jinsong Wang in an extensive interview.
Vaxxinity CEO On Getting Rid Of Alzheimer’s And Migraines, Preventing Heart Disease And COVID-19
November 18, 2022 03:31 - 19 minutes - 13.7 MBUS-based Vaxxinity Inc’s co-founder and CEO Mei Mei Hu and her team are developing peptide-based vaccines to treat or prevent chronic illnesses like cardiovascular disease and infectious ones like COVID-19. Scrip spoke to her on when data readouts from these immunotherapeutic candidates can be expected and her plans to make them accessible. Whether or not UB-313 will prove to be the first choice to prevent migraines and VXX-401, a vaccine to prevent hypercholesterolemia, will be cheaper than ...
レポート要約 - 1] 臨床試験を牽引するアジア太平洋地域
November 16, 2022 06:10 - 5 minutes - 12.1 MBレポート『臨床試験を牽引するアジア太平洋地域～Asia Pacific as a Clinical Trials Powerhouse（2022年10月発行）』を要約し、短い音声ファイルにまとめました。臨床試験データベース「Trialtrove」のデータを基に、2012年から2021年の10年間におけるAPAC（アジア太平洋地域）の臨床試験状況を分析しています。 フルレポートをお読みになりたい方は、下記のURLからダウンロードしてください。APACにおける治験依頼者、対象疾患、試験の種類などについても詳しく解説しています。 【日本語版】 https://images.intelligence.informa.com/Web/InformaUKLimited/%7Bc5d2830a-4459-414d-ae16-795bbaba8aaf%7D_J202012-0049-21_APAC_paper_final_ORIGINAL_rev1012_JP.pdf 【英語版】 https://images.intelligence.informa.com/Web/InformaUKLi...
2022년 빅파마M&A 선두주자는 화이자, 인수합병 또 나올까?
November 13, 2022 23:20 - 3 minutes - 8.51 MB머크가 400억달러 규모의 씨젠 인수에서 손을 떼는 등 빅파마들이 여전히 인수합병에 나서는 것을 자제하고 있다는 Scrip 기사를 요약한 내용입니다. https://scrip.pharmaintelligence.informa.com/SC147191/Pfizer-Leads-Big-Pharma-MA-In-2022--But-Is-There-More-To-Come
Drug Fix: Election Fallout, IRA Impacting Product Development, Updated FDA Expanded Access Policy
November 11, 2022 17:20 - 36 minutes - 22.4 MBPink Sheet reporters and editor discuss the impact of the midterm elections on the US Food and Drug Administration, the Inflation Reduction Act’s effects on drug development, and adjustments to the FDA’s expanded access guidance.
Accenture's Petra Jantzer on M&A trends and what it means for execs
November 08, 2022 14:57 - 17 minutes - 6.42 MBAccenture's Petra Jantzer on M&A trends and what it means for execs by Citeline